Bold explorations in funding, feedstocks, and biocatalysts at Next Generation Bio-Based Chemicals

At the Third Annual Next Generation Bio-Based Chemicals conference where Lux moderated a panel on carbon to chemicals, discussions centered around funding, the future of biocatalyst development, and — not surprisingly — feedstocks.

One panel touched on trends in funding bio-based chemical projects...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

LanzaTech and Carbon Engineering partner to commercialize SAF using CO₂ from direct air capture

News Commentary | July 29, 2021

The companies announced the launch of the AtmosFUEL project, which will study the feasibility of producing 100 million liters of SAF using atmospheric CO2. British Airways and Virgin Atlantic are also contributing to the project, which will bring the direct air capture (DAC) technology from Carbon ... Not part of subscription

Huh? CO₂-to-cellulose? Rubi Laboratories raises USD 4.5 million to develop CO₂-derived viscose

News Commentary | February 25, 2022

At the intersection of synthetic biology, CO2 utilization, and cellulosic fibers is Rubi Laboratories. Rubi is aiming to produce carbon‑negative viscose using its enzyme‑based CO2‑to‑cellulose technology. Unlike other CO2‑derived fiber developers like LanzaTech, Newlight Technologies, and Fairbrics ... Not part of subscription

Getting innovation timing right: SPAC deal sets LanzaTech up for growth and success

Case Study | March 24, 2022

LanzaTech initially began as a company seeking to commercialize its microbial gas‑to‑alcohol technology. Despite the skepticism and challenges that come with synthetic biology conversion, the company has made considerable commercial strides and established itself in multiple downstream CO2 ... Not part of subscription